← Evidence map

ArticleAnnals of internal medicine2017

In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks.

Fred Arthur ZarPubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2017

this papercites it

In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks. | OpenQuestion